These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 20542809)

  • 21. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
    Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: relationship with intimal thickening and pharmacological applications.
    Louis H; Lacolley P; Kakou A; Cattan V; Daret D; Safar M; Bonnet J; Daniel Lamazière JM
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):131-8. PubMed ID: 16445712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.
    Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S
    Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
    Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
    Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
    Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
    Huang C; Zhao J; Zhu Y
    J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
    Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
    Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethanol inhibits pulse pressure-induced vascular smooth muscle cell migration by differentially modulating plasminogen activator inhibitor type 1, matrix metalloproteinase-2 and -9.
    Cullen JP; Sayeed S; Kim Y; Theodorakis NG; Sitzmann JV; Cahill PA; Redmond EM
    Thromb Haemost; 2005 Sep; 94(3):639-45. PubMed ID: 16268483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
    Parry TJ; Brosius R; Thyagarajan R; Carter D; Argentieri D; Falotico R; Siekierka J
    Eur J Pharmacol; 2005 Nov; 524(1-3):19-29. PubMed ID: 16271360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.
    Islam MM; Franco CD; Courtman DW; Bendeck MP
    Am J Pathol; 2003 Oct; 163(4):1557-66. PubMed ID: 14507662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.